Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2

Area of Science:

• Biochemistry
• Genetics
• Neuroscience

Background:

• Mutations in Leucine-rich repeat kinase 2 (LRRK2) are linked to Parkinson's disease (PD) pathogenesis.
• Mouse models are crucial for studying PD-associated LRRK2 mutations, but direct protein comparisons are lacking.

Purpose of the Study:

• To biochemically compare human and mouse LRRK2 protein properties.
• To investigate the impact of PD-associated mutations on species-specific LRRK2 behavior.

Main Methods:

• Comparative biochemical analysis of human and mouse LRRK2 proteins.
• In vitro assessment of LRRK2 kinase activity and stability.
• Evaluation of PD-associated mutations (e.g., G2019S) and variations near position 2385.

Main Results:

• Mouse Lrrk2 exhibits greater stability but significantly lower kinase activity than human LRRK2.
• Conserved mutations like G2019S affect both species similarly.
• Non-conserved variations (position 2385) lead to divergent in vitro functional differences between human and mouse LRRK2.

Conclusions:

• Structural differences between human and mouse LRRK2 underlie their distinct biochemical properties.
• These findings are critical for the accurate modeling of LRRK2 mutations in mice.
• The results have significant implications for the preclinical testing of Parkinson's disease therapies in animal models.